Oxford University's malaria vaccine has been approved for use in Ghana as the country tries to reduce the 600,000 deaths a year from the disease.
A keenly-watched malaria vaccine from Oxford University has secured its first approval, in Ghana, as the African country ramps up efforts to combat the mosquito-borne disease that kills a child every minute.
After decades of work, the first malaria vaccine, Mosquirix from British drugmaker GSK, was last year endorsed by the World Health Organization , but a lack of funding and commercial potential has thwarted the company’s capacity to produce as many doses as needed.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Russian mercenaries control 80% of Bakhmut, claims Wagner Group chiefUkrainian officials have denied claims from Wagner Group founder Yevgeny Prigozhin that Russian forces control ‘80%’ of Bakhmut.
Weiterlesen »
Pensioner, 80, dies in horror three-car crash near Scots hotelTwo other men were treated at the scene of the crash on Tuesday evening near the Balbirnie Hotel with several emergency service vehicles in attendance.
Weiterlesen »
Boston Expected to Hit 80 Degrees Thursday for First Time Since SeptemberThursday is very warm for April, with high temperatures likely to challenge records. Expect mostly sunny skies, and highs into the middle 80s inland. Coastal locations could be as much as 30 degrees cooler, if the wind direction comes in off the water. Friday starts mostly sunny, and very mild. Inland locations again close in on 80 degrees, but a…
Weiterlesen »
Tesco to open another Preston city centre storeThe chain now has Express stores within 10 minutes of 80% of the UK population
Weiterlesen »
'Great Scots' added to Oxford Dictionary of National BiographyGreat Scots added to Oxford Dictionary of National Biography
Weiterlesen »
The Parkinson's Pandemic: from the importance of early diagnosis to digital solutionsNews Medical spoke to Michele Hu, Consultant Neurologist at Oxford University Hospitals and Professor of Clinical Neuroscience at the Nuffield Department of Clinical Neurosciences, University of Oxford, about prodromal Parkinson's and what the future looks like for this neurological disease.
Weiterlesen »